Clinical Trial Update: Docetaxel in Treating Patients With Advanced Cancer of the Cervix [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel in patients with advanced cervical cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Grupo Oncologico Cooperativo del Sur | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED